Selected data models

You must log in to select data models for download or further analysis.

12 Search results.
Relevance Rating New first Old first

Eligibility Type 2 Diabetes NCT00641251

- 4/21/18 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
DSS: Diabetes Surgery Study - Intensive Medical Management of Type 2 Diabetes, With and Without Gastric Bypass Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT00641251

Eligibility Diabetes Mellitus, Type 2 NCT01970462

- 11/5/19 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT01970462

Eligibility Type II Diabetes NCT01330251

- 1/19/19 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Criteria, Exclusion Criteria
The Effect of Gastric Bypass Surgery on Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01330251

Eligibility Type 2 Diabetes Mellitus NCT02287285

- 7/17/19 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Determinants of Diabetes Remission After Gastric Bypass Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT02287285

Eligibility Type II Diabetes Mellitus NCT00887302

- 11/30/18 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Metabolics of Roux-en-Y Gastric Bypass (RYGB) With Gastrostomy; ODM derived from: https://clinicaltrials.gov/show/NCT00887302

Eligibility Type II Diabetes NCT00694278

- 12/1/18 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Clinical Evaluation of the Effect of Duodenal-Jejunal Bypass on Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00694278

Eligibility Type II Diabetes Mellitus NCT00540462

- 9/17/21 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Prospective Randomized Trials of Gastric Bypass Surgery in Patients With Type II Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT00540462

Eligibility Type 2 Diabetes NCT00456105

- 7/4/17 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
The Effect of a Diabetes Action Team in Patients Post Infrainguinal Bypass Surgery With and Without Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00456105

Eligibility Diabetes Mellitus, Type 2 NCT00566189

- 2/25/18 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
New Frontiers on Bariatric Surgical Procedures: Classical Bypass for Type-2 Diabetic Patients With Obesity Grade I; ODM derived from: https://clinicaltrials.gov/show/NCT00566189

Eligibility Type II Diabetes in the Not so Obese NCT02041234

- 7/24/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT02041234

Eligibility Diabetes Mellitus, Non-Insulin-Dependent NCT02091323

- 12/19/18 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Criteria, Exclusion Criteria
Effect of Laparoscopic Roux-en-Y Gastric Bypass Surgery on Non-severe Obesity With Type 2 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT02091323

Pharmacokinetics of an oral contraceptive co-administered with Albiglutide in women - 107032 - Adjudication Events - Coronary Revascularization

- 1/7/19 - 1 form, 10 itemgroups, 52 items, 1 language
Itemgroups: Administrative data, Coronary Revascularization, Percutaneous coronary intervention, Coronary artery bypass graft procedure, Specify other coronary revascularization procedure, AE Details, Enzyme Value Data, CK-MB, Troponin I, Troponin T
Study ID: 107032 Clinical Study ID: GLP107032 Study Title: An open-label study to evaluate the pharmacokinetics of an oral contraceptive containing Norethindrone and Ethinyl Estradiol when co-administered with GSK716155 in healthy adult female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01077505 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial